Mwandishi:
Mhariri:
Imeboreshwa:
6 Juni 2026, 03:55:58
Management of Moderate covid-19
Moderate covid-19
There is no single curative (“magic-bullet”) therapy for COVID-19. The disease is a multi-phase viral-inflammatory syndrome, therefore treatment requires:
Stage-specific therapy
Organ support
Thrombosis prevention
Careful monitoring for deterioration
Management differs according to severity:
Mild disease (Home care)
Moderate disease (Pneumonia)
Severe disease (Severe pneumonia)
Critical disease
MODERATE COVID-19 DISEASE (PNEUMONIA)
Clinical definition
Pneumonia with SpO₂ ≥ 90% on room air
Goals of Care
Prevent deterioration to severe disease
Reduce inflammation
Treat bacterial superinfection
Treatment/management protocol
Supportive care
Same supplements as mild disease.
Anti-Inflammatory therapy
Dexamethasone 6 mg PO OD for 5 days or Prednisolone 20 mg PO OD for 5 days
Antibiotics (If suspected superinfection)
Option 1
Azithromycin 500 mg OD × 5 daysPLUS
Amoxicillin/Clavulanate 625 mg BD × 7 days
Option 2
Azithromycin 500 mg OD × 5 daysPLUS
Amoxicillin 500 mg TDS × 7 days
Option 3
Azithromycin 500 mg OD × 5 daysPLUS
Ceftriaxone 1 g OD × 5 days
Monitoring
Daily symptom review
Oxygen saturation monitoring
Educate on danger signs
CORE PRINCIPLE OF COVID-19 MANAGEMENT
Mild → symptomatic care
Moderate → anti-inflammatory therapy
Severe → oxygen + steroids + anticoagulation
Critical → organ support + ICU care
Imeandikwa:
26 Mei 2026, 07:47:50
